Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Nation

Showing results (161-170 of 247) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|January 18, 2018
Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical ModelingCornelia B Landersdorfer, Rajbharan Yadav, Kate E Rogers, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2015
Reviving old antibioticsUrsula Theuretzbacher, Françoise Van Bambeke, Rafael Cantón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2011
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamaseHanna Sidjabat, Graeme R Nimmo, Timothy R Walsh, et al.
Organic & Biomolecular Chemistry|August 17, 2017
The first total synthesis and solution structure of a polypeptin, PE2, a cyclic lipopeptide with broad spectrum antibiotic activitySimon J Mountford, Biswaranjan Mohanty, Kade D Roberts, et al.
Journal of Clinical Microbiology|July 10, 2009
Stable polymyxin B susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite persistent recovery of these organisms from respiratory secretions of patients with ventilator-associated pneumonia treated with this drugAlexandre P Zavascki, Jian Li, Roger L Nation, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2012
Hospital costs, length of stay and mortality attributable to invasive scedosporiosis in haematology patientsSiow-Chin Heng, Monica A Slavin, Sharon C-A Chen, et al.
International Journal of Antimicrobial Agents|February 28, 2018
Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection modelZackery P Bulman, Miao Zhao, Michael J Satlin, et al.
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Scientific Reports|May 20, 2016
Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage RegimensSoon-Ee Cheah, Matthew D Johnson, Yan Zhu, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2017
Gelofusine Ameliorates Colistin-Induced NephrotoxicitySivashangarie S Sivanesan, Mohammad A K Azad, Elena K Schneider, et al.
Pageof 25

Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|January 18, 2018
Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical ModelingCornelia B Landersdorfer, Rajbharan Yadav, Kate E Rogers, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2015
Reviving old antibioticsUrsula Theuretzbacher, Françoise Van Bambeke, Rafael Cantón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2011
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamaseHanna Sidjabat, Graeme R Nimmo, Timothy R Walsh, et al.
Organic & Biomolecular Chemistry|August 17, 2017
The first total synthesis and solution structure of a polypeptin, PE2, a cyclic lipopeptide with broad spectrum antibiotic activitySimon J Mountford, Biswaranjan Mohanty, Kade D Roberts, et al.
Journal of Clinical Microbiology|July 10, 2009
Stable polymyxin B susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite persistent recovery of these organisms from respiratory secretions of patients with ventilator-associated pneumonia treated with this drugAlexandre P Zavascki, Jian Li, Roger L Nation, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2012
Hospital costs, length of stay and mortality attributable to invasive scedosporiosis in haematology patientsSiow-Chin Heng, Monica A Slavin, Sharon C-A Chen, et al.
International Journal of Antimicrobial Agents|February 28, 2018
Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection modelZackery P Bulman, Miao Zhao, Michael J Satlin, et al.
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Scientific Reports|May 20, 2016
Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage RegimensSoon-Ee Cheah, Matthew D Johnson, Yan Zhu, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2017
Gelofusine Ameliorates Colistin-Induced NephrotoxicitySivashangarie S Sivanesan, Mohammad A K Azad, Elena K Schneider, et al.
Pageof 25